Upstream effect for atrial fibrillation: still a dilemma? - Wikidata - wikimedia - TriplyDB

Upstream effect for atrial fibrillation: still a dilemma?

Upstream effect for atrial fibrillation: still a dilemma?

http://www.wikidata.org/entity/Q37804417

about

Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score.Intracellular lactate signaling cascade in atrial remodeling of mitral valvular patients with atrial fibrillation.Clinical update on the management of atrial fibrillation.Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation.Serum level of transforming growth factor beta 1 is associated with left atrial voltage in patients with chronic atrial fibrillation.

P2860

Q33984012-03CF229D-5FFE-47CF-88E3-446DE7CD0D8B Q36690912-4E6DDC55-3725-49A6-923A-B31F35359113 Q38095871-B076168C-9053-40E1-A08A-50282E5FE175 Q46027836-E1DA21CA-C945-4913-9F7E-0711F506247F Q49864738-03D41DC6-BC4D-4E2A-862D-F03D13BC6E1D

P2860

Upstream effect for atrial fibrillation: still a dilemma?

http://www.wikidata.org/entity/Q37804417

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Upstream effect for atrial fibrillation: still a dilemma?

@en

Upstream effect for atrial fibrillation: still a dilemma?

@nl

type

label

Upstream effect for atrial fibrillation: still a dilemma?

@en

Upstream effect for atrial fibrillation: still a dilemma?

@nl

prefLabel

Upstream effect for atrial fibrillation: still a dilemma?

@en

Upstream effect for atrial fibrillation: still a dilemma?

@nl

P1433

Q37804417-14E56128-3BD6-4877-A9C6-BEDA0CB98D6B

P1476

Q37804417-A6C26915-5C96-4D39-B20F-4C11061410ED

P2093

Q37804417-5E129BC0-D61D-4D52-B9EB-C753C9FDD34F

Q37804417-66C59BC3-91C2-468A-89C9-80AC3EE3E615

Q37804417-7299A521-F91E-482B-9D39-B9A1E68E11AE

Q37804417-8074D564-94B8-4F5D-8C66-7F043FF0A17E

Q37804417-8A3DE1E3-DBDA-4D76-9F54-E25875D8337D

Q37804417-ACC0F838-720A-4C6D-BB0B-9EF3DC7A6D5D

Q37804417-C92141D2-72CF-4053-AA2C-5FFFFFF2CE77

Q37804417-D60FE741-7121-4FEB-B55C-C4F2B8F7509A

Q37804417-E1D9B5C5-90AB-4773-BC96-E5AD8921443D

P2860

Q37804417-04F5ABC9-3296-4E5F-B29A-D76AA8B52EE4

Q37804417-0A777CA1-CF4F-45E6-9717-02F8BDC96933

Q37804417-0C008BE3-9217-4709-B393-835B82DFAB5A

Q37804417-0DE68EE7-BC41-494E-B374-2EB0C8920314

Q37804417-13A58333-846F-4A6D-933E-EA306725C2A5

Q37804417-148A9AE5-CD94-46F1-BDFE-E58B1A766E90

Q37804417-14F9465D-268D-4599-9CDE-2CCFE65AA648

Q37804417-162C26C5-D191-44EB-855C-D9931F84A99C

Q37804417-1C971890-3800-4ABE-9A8E-1CB60FAC02D9

Q37804417-2444862A-B4CF-40EE-AC90-020ED1AE3974

P304

Q37804417-A31BD79D-1D7E-47D4-8C10-4D386791F28D

P31

Q37804417-A3015C89-85CD-468E-BEC4-A365348EE820

P356

Q37804417-3FB30E70-B2F1-4AAA-9D51-81907B9A98B6

P433

Q37804417-07A4951C-4FF7-42A0-A565-B3ABE30DBF62

P478

Q37804417-F50FA9C0-020E-41F5-B167-CB6E5D5A24C9

P50

Q37804417-A00CAB3F-EA00-4B16-B0DE-BFD81BE49651

P577

Q37804417-545CD68D-D05A-43C7-83DB-40837F495D64

P698

Q37804417-701C7CC0-7639-47B4-8EE4-EBF2EEE2E773

P921

Q37804417-6CD4B055-5CC5-4FA7-9CE8-ACA8DEBC2733

P356

J.1540-8159.2010.02942.X

P1433

Pacing and Clinical Electrophysiology

P1476

Upstream effect for atrial fibrillation: still a dilemma?

@en

P2093

Annamaria Martino

http://www.w3.org/2001/XMLSchema#string

Antonella Sette

http://www.w3.org/2001/XMLSchema#string

Antonio Ciccaglioni

http://www.w3.org/2001/XMLSchema#string

Ermenegildo De Ruvo

http://www.w3.org/2001/XMLSchema#string

Ernesto Lioy

http://www.w3.org/2001/XMLSchema#string

Francesco Fedele

http://www.w3.org/2001/XMLSchema#string

Giuseppe Giunta

http://www.w3.org/2001/XMLSchema#string

Leonardo Calò

http://www.w3.org/2001/XMLSchema#string

Lucia De Luca

http://www.w3.org/2001/XMLSchema#string

P2860

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.

Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials.

Aldosterone production is activated in failing ventricle in humans.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.

Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model.

Fish intake and risk of incident atrial fibrillation.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

P304

111-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1540-8159.2010.02942.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21029134

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation